nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—BCHE—Triamcinolone—psoriasis	0.145	0.262	CbGbCtD
Rivastigmine—CYP2D6—Hydroxyurea—psoriasis	0.066	0.119	CbGbCtD
Rivastigmine—CYP3A4—Calcitriol—psoriasis	0.0494	0.0894	CbGbCtD
Rivastigmine—CYP2D6—Cholecalciferol—psoriasis	0.04	0.0724	CbGbCtD
Rivastigmine—CYP3A4—Methoxsalen—psoriasis	0.0384	0.0695	CbGbCtD
Rivastigmine—CYP2D6—Cyclosporine—psoriasis	0.0263	0.0476	CbGbCtD
Rivastigmine—CYP3A4—Cholecalciferol—psoriasis	0.0254	0.046	CbGbCtD
Rivastigmine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0221	0.0399	CbGbCtD
Rivastigmine—CYP3A4—Triamcinolone—psoriasis	0.0221	0.0399	CbGbCtD
Rivastigmine—CYP3A4—Betamethasone—psoriasis	0.0189	0.0342	CbGbCtD
Rivastigmine—CYP3A4—Prednisolone—psoriasis	0.0187	0.0338	CbGbCtD
Rivastigmine—CYP3A4—Hydrocortisone—psoriasis	0.0177	0.032	CbGbCtD
Rivastigmine—CYP3A4—Prednisone—psoriasis	0.0176	0.0319	CbGbCtD
Rivastigmine—CYP2D6—Dexamethasone—psoriasis	0.0173	0.0313	CbGbCtD
Rivastigmine—CYP3A4—Cyclosporine—psoriasis	0.0167	0.0302	CbGbCtD
Rivastigmine—CYP3A4—Dexamethasone—psoriasis	0.011	0.0199	CbGbCtD
Rivastigmine—Vomiting—Mycophenolic acid—psoriasis	6.18e-05	0.000138	CcSEcCtD
Rivastigmine—Discomfort—Dexamethasone—psoriasis	6.16e-05	0.000138	CcSEcCtD
Rivastigmine—Discomfort—Betamethasone—psoriasis	6.16e-05	0.000138	CcSEcCtD
Rivastigmine—Dyspepsia—Hydrocortisone—psoriasis	6.15e-05	0.000138	CcSEcCtD
Rivastigmine—Haemoglobin—Methotrexate—psoriasis	6.15e-05	0.000138	CcSEcCtD
Rivastigmine—Rash—Mycophenolic acid—psoriasis	6.13e-05	0.000137	CcSEcCtD
Rivastigmine—Dermatitis—Mycophenolic acid—psoriasis	6.13e-05	0.000137	CcSEcCtD
Rivastigmine—Pain—Prednisolone—psoriasis	6.12e-05	0.000137	CcSEcCtD
Rivastigmine—Haemorrhage—Methotrexate—psoriasis	6.12e-05	0.000137	CcSEcCtD
Rivastigmine—Hepatitis—Methotrexate—psoriasis	6.12e-05	0.000137	CcSEcCtD
Rivastigmine—Urticaria—Mycophenolate mofetil—psoriasis	6.1e-05	0.000136	CcSEcCtD
Rivastigmine—Headache—Mycophenolic acid—psoriasis	6.09e-05	0.000136	CcSEcCtD
Rivastigmine—Decreased appetite—Hydrocortisone—psoriasis	6.08e-05	0.000136	CcSEcCtD
Rivastigmine—Pharyngitis—Methotrexate—psoriasis	6.07e-05	0.000136	CcSEcCtD
Rivastigmine—Abdominal pain—Mycophenolate mofetil—psoriasis	6.07e-05	0.000136	CcSEcCtD
Rivastigmine—Body temperature increased—Mycophenolate mofetil—psoriasis	6.07e-05	0.000136	CcSEcCtD
Rivastigmine—Urinary tract disorder—Methotrexate—psoriasis	6.04e-05	0.000135	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Hydrocortisone—psoriasis	6.04e-05	0.000135	CcSEcCtD
Rivastigmine—Fatigue—Hydrocortisone—psoriasis	6.03e-05	0.000135	CcSEcCtD
Rivastigmine—Vision blurred—Prednisone—psoriasis	6.01e-05	0.000134	CcSEcCtD
Rivastigmine—Urethral disorder—Methotrexate—psoriasis	6e-05	0.000134	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Triamcinolone—psoriasis	6e-05	0.000134	CcSEcCtD
Rivastigmine—Pain—Hydrocortisone—psoriasis	5.98e-05	0.000134	CcSEcCtD
Rivastigmine—Oedema—Dexamethasone—psoriasis	5.97e-05	0.000134	CcSEcCtD
Rivastigmine—Oedema—Betamethasone—psoriasis	5.97e-05	0.000134	CcSEcCtD
Rivastigmine—Insomnia—Triamcinolone—psoriasis	5.95e-05	0.000133	CcSEcCtD
Rivastigmine—Infection—Betamethasone—psoriasis	5.93e-05	0.000133	CcSEcCtD
Rivastigmine—Infection—Dexamethasone—psoriasis	5.93e-05	0.000133	CcSEcCtD
Rivastigmine—Ill-defined disorder—Prednisone—psoriasis	5.91e-05	0.000132	CcSEcCtD
Rivastigmine—Paraesthesia—Triamcinolone—psoriasis	5.91e-05	0.000132	CcSEcCtD
Rivastigmine—Feeling abnormal—Prednisolone—psoriasis	5.9e-05	0.000132	CcSEcCtD
Rivastigmine—Visual impairment—Methotrexate—psoriasis	5.9e-05	0.000132	CcSEcCtD
Rivastigmine—Anaemia—Prednisone—psoriasis	5.89e-05	0.000132	CcSEcCtD
Rivastigmine—Shock—Dexamethasone—psoriasis	5.88e-05	0.000131	CcSEcCtD
Rivastigmine—Shock—Betamethasone—psoriasis	5.88e-05	0.000131	CcSEcCtD
Rivastigmine—Dyspnoea—Triamcinolone—psoriasis	5.87e-05	0.000131	CcSEcCtD
Rivastigmine—Nervous system disorder—Betamethasone—psoriasis	5.86e-05	0.000131	CcSEcCtD
Rivastigmine—Nervous system disorder—Dexamethasone—psoriasis	5.86e-05	0.000131	CcSEcCtD
Rivastigmine—Agitation—Prednisone—psoriasis	5.86e-05	0.000131	CcSEcCtD
Rivastigmine—Thrombocytopenia—Betamethasone—psoriasis	5.85e-05	0.000131	CcSEcCtD
Rivastigmine—Thrombocytopenia—Dexamethasone—psoriasis	5.85e-05	0.000131	CcSEcCtD
Rivastigmine—Tachycardia—Dexamethasone—psoriasis	5.83e-05	0.00013	CcSEcCtD
Rivastigmine—Tachycardia—Betamethasone—psoriasis	5.83e-05	0.00013	CcSEcCtD
Rivastigmine—Hypersensitivity—Cyclosporine—psoriasis	5.8e-05	0.00013	CcSEcCtD
Rivastigmine—Dyspepsia—Triamcinolone—psoriasis	5.8e-05	0.00013	CcSEcCtD
Rivastigmine—Erythema multiforme—Methotrexate—psoriasis	5.79e-05	0.000129	CcSEcCtD
Rivastigmine—Nausea—Mycophenolic acid—psoriasis	5.78e-05	0.000129	CcSEcCtD
Rivastigmine—Hyperhidrosis—Dexamethasone—psoriasis	5.77e-05	0.000129	CcSEcCtD
Rivastigmine—Hyperhidrosis—Betamethasone—psoriasis	5.77e-05	0.000129	CcSEcCtD
Rivastigmine—Feeling abnormal—Hydrocortisone—psoriasis	5.76e-05	0.000129	CcSEcCtD
Rivastigmine—Malaise—Prednisone—psoriasis	5.75e-05	0.000129	CcSEcCtD
Rivastigmine—Vertigo—Prednisone—psoriasis	5.73e-05	0.000128	CcSEcCtD
Rivastigmine—Eye disorder—Methotrexate—psoriasis	5.72e-05	0.000128	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Hydrocortisone—psoriasis	5.72e-05	0.000128	CcSEcCtD
Rivastigmine—Syncope—Prednisone—psoriasis	5.72e-05	0.000128	CcSEcCtD
Rivastigmine—Tinnitus—Methotrexate—psoriasis	5.71e-05	0.000128	CcSEcCtD
Rivastigmine—Anorexia—Dexamethasone—psoriasis	5.69e-05	0.000127	CcSEcCtD
Rivastigmine—Anorexia—Betamethasone—psoriasis	5.69e-05	0.000127	CcSEcCtD
Rivastigmine—Urticaria—Prednisolone—psoriasis	5.69e-05	0.000127	CcSEcCtD
Rivastigmine—Cardiac disorder—Methotrexate—psoriasis	5.68e-05	0.000127	CcSEcCtD
Rivastigmine—Fatigue—Triamcinolone—psoriasis	5.68e-05	0.000127	CcSEcCtD
Rivastigmine—Hypersensitivity—Mycophenolate mofetil—psoriasis	5.65e-05	0.000126	CcSEcCtD
Rivastigmine—Asthenia—Cyclosporine—psoriasis	5.64e-05	0.000126	CcSEcCtD
Rivastigmine—Pain—Triamcinolone—psoriasis	5.63e-05	0.000126	CcSEcCtD
Rivastigmine—Loss of consciousness—Prednisone—psoriasis	5.6e-05	0.000125	CcSEcCtD
Rivastigmine—Hypotension—Betamethasone—psoriasis	5.58e-05	0.000125	CcSEcCtD
Rivastigmine—Hypotension—Dexamethasone—psoriasis	5.58e-05	0.000125	CcSEcCtD
Rivastigmine—Pruritus—Cyclosporine—psoriasis	5.57e-05	0.000124	CcSEcCtD
Rivastigmine—Urticaria—Hydrocortisone—psoriasis	5.55e-05	0.000124	CcSEcCtD
Rivastigmine—Angiopathy—Methotrexate—psoriasis	5.55e-05	0.000124	CcSEcCtD
Rivastigmine—Abdominal pain—Hydrocortisone—psoriasis	5.53e-05	0.000124	CcSEcCtD
Rivastigmine—Body temperature increased—Hydrocortisone—psoriasis	5.53e-05	0.000124	CcSEcCtD
Rivastigmine—Convulsion—Prednisone—psoriasis	5.52e-05	0.000123	CcSEcCtD
Rivastigmine—Mediastinal disorder—Methotrexate—psoriasis	5.52e-05	0.000123	CcSEcCtD
Rivastigmine—Asthenia—Mycophenolate mofetil—psoriasis	5.51e-05	0.000123	CcSEcCtD
Rivastigmine—Hypertension—Prednisone—psoriasis	5.5e-05	0.000123	CcSEcCtD
Rivastigmine—Chills—Methotrexate—psoriasis	5.49e-05	0.000123	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Dexamethasone—psoriasis	5.44e-05	0.000122	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Betamethasone—psoriasis	5.44e-05	0.000122	CcSEcCtD
Rivastigmine—Pruritus—Mycophenolate mofetil—psoriasis	5.43e-05	0.000121	CcSEcCtD
Rivastigmine—Arthralgia—Prednisone—psoriasis	5.43e-05	0.000121	CcSEcCtD
Rivastigmine—Myalgia—Prednisone—psoriasis	5.43e-05	0.000121	CcSEcCtD
Rivastigmine—Feeling abnormal—Triamcinolone—psoriasis	5.43e-05	0.000121	CcSEcCtD
Rivastigmine—Anxiety—Prednisone—psoriasis	5.41e-05	0.000121	CcSEcCtD
Rivastigmine—Alopecia—Methotrexate—psoriasis	5.41e-05	0.000121	CcSEcCtD
Rivastigmine—Insomnia—Dexamethasone—psoriasis	5.4e-05	0.000121	CcSEcCtD
Rivastigmine—Insomnia—Betamethasone—psoriasis	5.4e-05	0.000121	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	5.39e-05	0.000121	CcSEcCtD
Rivastigmine—Diarrhoea—Cyclosporine—psoriasis	5.38e-05	0.00012	CcSEcCtD
Rivastigmine—Paraesthesia—Dexamethasone—psoriasis	5.36e-05	0.00012	CcSEcCtD
Rivastigmine—Paraesthesia—Betamethasone—psoriasis	5.36e-05	0.00012	CcSEcCtD
Rivastigmine—Discomfort—Prednisone—psoriasis	5.36e-05	0.00012	CcSEcCtD
Rivastigmine—Mental disorder—Methotrexate—psoriasis	5.36e-05	0.00012	CcSEcCtD
Rivastigmine—Erythema—Methotrexate—psoriasis	5.33e-05	0.000119	CcSEcCtD
Rivastigmine—Malnutrition—Methotrexate—psoriasis	5.33e-05	0.000119	CcSEcCtD
Rivastigmine—Hypersensitivity—Prednisolone—psoriasis	5.27e-05	0.000118	CcSEcCtD
Rivastigmine—Dyspepsia—Dexamethasone—psoriasis	5.26e-05	0.000118	CcSEcCtD
Rivastigmine—Dyspepsia—Betamethasone—psoriasis	5.26e-05	0.000118	CcSEcCtD
Rivastigmine—Diarrhoea—Mycophenolate mofetil—psoriasis	5.25e-05	0.000117	CcSEcCtD
Rivastigmine—Urticaria—Triamcinolone—psoriasis	5.23e-05	0.000117	CcSEcCtD
Rivastigmine—Dysgeusia—Methotrexate—psoriasis	5.22e-05	0.000117	CcSEcCtD
Rivastigmine—Body temperature increased—Triamcinolone—psoriasis	5.2e-05	0.000116	CcSEcCtD
Rivastigmine—Dizziness—Cyclosporine—psoriasis	5.2e-05	0.000116	CcSEcCtD
Rivastigmine—Oedema—Prednisone—psoriasis	5.2e-05	0.000116	CcSEcCtD
Rivastigmine—Decreased appetite—Dexamethasone—psoriasis	5.19e-05	0.000116	CcSEcCtD
Rivastigmine—Decreased appetite—Betamethasone—psoriasis	5.19e-05	0.000116	CcSEcCtD
Rivastigmine—Infection—Prednisone—psoriasis	5.17e-05	0.000116	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Dexamethasone—psoriasis	5.16e-05	0.000115	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Betamethasone—psoriasis	5.16e-05	0.000115	CcSEcCtD
Rivastigmine—Back pain—Methotrexate—psoriasis	5.15e-05	0.000115	CcSEcCtD
Rivastigmine—Hypersensitivity—Hydrocortisone—psoriasis	5.15e-05	0.000115	CcSEcCtD
Rivastigmine—Fatigue—Betamethasone—psoriasis	5.15e-05	0.000115	CcSEcCtD
Rivastigmine—Fatigue—Dexamethasone—psoriasis	5.15e-05	0.000115	CcSEcCtD
Rivastigmine—Shock—Prednisone—psoriasis	5.12e-05	0.000114	CcSEcCtD
Rivastigmine—Pain—Dexamethasone—psoriasis	5.11e-05	0.000114	CcSEcCtD
Rivastigmine—Pain—Betamethasone—psoriasis	5.11e-05	0.000114	CcSEcCtD
Rivastigmine—Nervous system disorder—Prednisone—psoriasis	5.1e-05	0.000114	CcSEcCtD
Rivastigmine—Tachycardia—Prednisone—psoriasis	5.08e-05	0.000114	CcSEcCtD
Rivastigmine—Dizziness—Mycophenolate mofetil—psoriasis	5.08e-05	0.000113	CcSEcCtD
Rivastigmine—Skin disorder—Prednisone—psoriasis	5.05e-05	0.000113	CcSEcCtD
Rivastigmine—Hyperhidrosis—Prednisone—psoriasis	5.03e-05	0.000112	CcSEcCtD
Rivastigmine—Vision blurred—Methotrexate—psoriasis	5.02e-05	0.000112	CcSEcCtD
Rivastigmine—Asthenia—Hydrocortisone—psoriasis	5.02e-05	0.000112	CcSEcCtD
Rivastigmine—Vomiting—Cyclosporine—psoriasis	5e-05	0.000112	CcSEcCtD
Rivastigmine—Rash—Cyclosporine—psoriasis	4.96e-05	0.000111	CcSEcCtD
Rivastigmine—Anorexia—Prednisone—psoriasis	4.96e-05	0.000111	CcSEcCtD
Rivastigmine—Dermatitis—Cyclosporine—psoriasis	4.96e-05	0.000111	CcSEcCtD
Rivastigmine—Pruritus—Hydrocortisone—psoriasis	4.95e-05	0.000111	CcSEcCtD
Rivastigmine—Ill-defined disorder—Methotrexate—psoriasis	4.94e-05	0.000111	CcSEcCtD
Rivastigmine—Headache—Cyclosporine—psoriasis	4.93e-05	0.00011	CcSEcCtD
Rivastigmine—Anaemia—Methotrexate—psoriasis	4.92e-05	0.00011	CcSEcCtD
Rivastigmine—Feeling abnormal—Dexamethasone—psoriasis	4.92e-05	0.00011	CcSEcCtD
Rivastigmine—Feeling abnormal—Betamethasone—psoriasis	4.92e-05	0.00011	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Dexamethasone—psoriasis	4.88e-05	0.000109	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Betamethasone—psoriasis	4.88e-05	0.000109	CcSEcCtD
Rivastigmine—Vomiting—Mycophenolate mofetil—psoriasis	4.88e-05	0.000109	CcSEcCtD
Rivastigmine—Hypersensitivity—Triamcinolone—psoriasis	4.85e-05	0.000108	CcSEcCtD
Rivastigmine—Rash—Mycophenolate mofetil—psoriasis	4.84e-05	0.000108	CcSEcCtD
Rivastigmine—Dermatitis—Mycophenolate mofetil—psoriasis	4.83e-05	0.000108	CcSEcCtD
Rivastigmine—Headache—Mycophenolate mofetil—psoriasis	4.81e-05	0.000108	CcSEcCtD
Rivastigmine—Malaise—Methotrexate—psoriasis	4.8e-05	0.000107	CcSEcCtD
Rivastigmine—Vertigo—Methotrexate—psoriasis	4.79e-05	0.000107	CcSEcCtD
Rivastigmine—Diarrhoea—Hydrocortisone—psoriasis	4.78e-05	0.000107	CcSEcCtD
Rivastigmine—Urticaria—Dexamethasone—psoriasis	4.75e-05	0.000106	CcSEcCtD
Rivastigmine—Urticaria—Betamethasone—psoriasis	4.75e-05	0.000106	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Prednisone—psoriasis	4.74e-05	0.000106	CcSEcCtD
Rivastigmine—Dizziness—Prednisolone—psoriasis	4.73e-05	0.000106	CcSEcCtD
Rivastigmine—Asthenia—Triamcinolone—psoriasis	4.72e-05	0.000106	CcSEcCtD
Rivastigmine—Body temperature increased—Dexamethasone—psoriasis	4.72e-05	0.000106	CcSEcCtD
Rivastigmine—Body temperature increased—Betamethasone—psoriasis	4.72e-05	0.000106	CcSEcCtD
Rivastigmine—Abdominal pain—Dexamethasone—psoriasis	4.72e-05	0.000106	CcSEcCtD
Rivastigmine—Abdominal pain—Betamethasone—psoriasis	4.72e-05	0.000106	CcSEcCtD
Rivastigmine—Insomnia—Prednisone—psoriasis	4.71e-05	0.000105	CcSEcCtD
Rivastigmine—Nausea—Cyclosporine—psoriasis	4.67e-05	0.000104	CcSEcCtD
Rivastigmine—Paraesthesia—Prednisone—psoriasis	4.67e-05	0.000104	CcSEcCtD
Rivastigmine—Pruritus—Triamcinolone—psoriasis	4.66e-05	0.000104	CcSEcCtD
Rivastigmine—Cough—Methotrexate—psoriasis	4.65e-05	0.000104	CcSEcCtD
Rivastigmine—Dizziness—Hydrocortisone—psoriasis	4.62e-05	0.000103	CcSEcCtD
Rivastigmine—Convulsion—Methotrexate—psoriasis	4.62e-05	0.000103	CcSEcCtD
Rivastigmine—Dyspepsia—Prednisone—psoriasis	4.58e-05	0.000102	CcSEcCtD
Rivastigmine—Nausea—Mycophenolate mofetil—psoriasis	4.56e-05	0.000102	CcSEcCtD
Rivastigmine—Arthralgia—Methotrexate—psoriasis	4.54e-05	0.000101	CcSEcCtD
Rivastigmine—Myalgia—Methotrexate—psoriasis	4.54e-05	0.000101	CcSEcCtD
Rivastigmine—Chest pain—Methotrexate—psoriasis	4.54e-05	0.000101	CcSEcCtD
Rivastigmine—Decreased appetite—Prednisone—psoriasis	4.52e-05	0.000101	CcSEcCtD
Rivastigmine—Rash—Prednisolone—psoriasis	4.51e-05	0.000101	CcSEcCtD
Rivastigmine—Dermatitis—Prednisolone—psoriasis	4.51e-05	0.000101	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	4.5e-05	0.000101	CcSEcCtD
Rivastigmine—Fatigue—Prednisone—psoriasis	4.49e-05	0.0001	CcSEcCtD
Rivastigmine—Headache—Prednisolone—psoriasis	4.48e-05	0.0001	CcSEcCtD
Rivastigmine—Discomfort—Methotrexate—psoriasis	4.48e-05	0.0001	CcSEcCtD
Rivastigmine—Constipation—Prednisone—psoriasis	4.45e-05	9.95e-05	CcSEcCtD
Rivastigmine—Vomiting—Hydrocortisone—psoriasis	4.45e-05	9.94e-05	CcSEcCtD
Rivastigmine—Rash—Hydrocortisone—psoriasis	4.41e-05	9.86e-05	CcSEcCtD
Rivastigmine—Dermatitis—Hydrocortisone—psoriasis	4.4e-05	9.85e-05	CcSEcCtD
Rivastigmine—Confusional state—Methotrexate—psoriasis	4.38e-05	9.8e-05	CcSEcCtD
Rivastigmine—Headache—Hydrocortisone—psoriasis	4.38e-05	9.79e-05	CcSEcCtD
Rivastigmine—Dizziness—Triamcinolone—psoriasis	4.35e-05	9.73e-05	CcSEcCtD
Rivastigmine—Infection—Methotrexate—psoriasis	4.32e-05	9.66e-05	CcSEcCtD
Rivastigmine—Feeling abnormal—Prednisone—psoriasis	4.29e-05	9.59e-05	CcSEcCtD
Rivastigmine—Asthenia—Betamethasone—psoriasis	4.29e-05	9.58e-05	CcSEcCtD
Rivastigmine—Asthenia—Dexamethasone—psoriasis	4.29e-05	9.58e-05	CcSEcCtD
Rivastigmine—Nervous system disorder—Methotrexate—psoriasis	4.26e-05	9.53e-05	CcSEcCtD
Rivastigmine—Thrombocytopenia—Methotrexate—psoriasis	4.26e-05	9.52e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Prednisone—psoriasis	4.25e-05	9.51e-05	CcSEcCtD
Rivastigmine—Nausea—Prednisolone—psoriasis	4.25e-05	9.51e-05	CcSEcCtD
Rivastigmine—Pruritus—Betamethasone—psoriasis	4.23e-05	9.45e-05	CcSEcCtD
Rivastigmine—Pruritus—Dexamethasone—psoriasis	4.23e-05	9.45e-05	CcSEcCtD
Rivastigmine—Skin disorder—Methotrexate—psoriasis	4.22e-05	9.44e-05	CcSEcCtD
Rivastigmine—Hyperhidrosis—Methotrexate—psoriasis	4.2e-05	9.4e-05	CcSEcCtD
Rivastigmine—Vomiting—Triamcinolone—psoriasis	4.19e-05	9.36e-05	CcSEcCtD
Rivastigmine—Nausea—Hydrocortisone—psoriasis	4.15e-05	9.29e-05	CcSEcCtD
Rivastigmine—Rash—Triamcinolone—psoriasis	4.15e-05	9.28e-05	CcSEcCtD
Rivastigmine—Dermatitis—Triamcinolone—psoriasis	4.15e-05	9.27e-05	CcSEcCtD
Rivastigmine—Anorexia—Methotrexate—psoriasis	4.14e-05	9.27e-05	CcSEcCtD
Rivastigmine—Urticaria—Prednisone—psoriasis	4.13e-05	9.24e-05	CcSEcCtD
Rivastigmine—Headache—Triamcinolone—psoriasis	4.12e-05	9.22e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Prednisone—psoriasis	4.11e-05	9.2e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Prednisone—psoriasis	4.11e-05	9.2e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Betamethasone—psoriasis	4.09e-05	9.14e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Dexamethasone—psoriasis	4.09e-05	9.14e-05	CcSEcCtD
Rivastigmine—Hypotension—Methotrexate—psoriasis	4.06e-05	9.08e-05	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Methotrexate—psoriasis	3.96e-05	8.86e-05	CcSEcCtD
Rivastigmine—Dizziness—Betamethasone—psoriasis	3.95e-05	8.83e-05	CcSEcCtD
Rivastigmine—Dizziness—Dexamethasone—psoriasis	3.95e-05	8.83e-05	CcSEcCtD
Rivastigmine—Insomnia—Methotrexate—psoriasis	3.93e-05	8.79e-05	CcSEcCtD
Rivastigmine—Nausea—Triamcinolone—psoriasis	3.91e-05	8.74e-05	CcSEcCtD
Rivastigmine—Paraesthesia—Methotrexate—psoriasis	3.9e-05	8.73e-05	CcSEcCtD
Rivastigmine—Dyspnoea—Methotrexate—psoriasis	3.88e-05	8.67e-05	CcSEcCtD
Rivastigmine—Somnolence—Methotrexate—psoriasis	3.87e-05	8.64e-05	CcSEcCtD
Rivastigmine—Hypersensitivity—Prednisone—psoriasis	3.83e-05	8.57e-05	CcSEcCtD
Rivastigmine—Dyspepsia—Methotrexate—psoriasis	3.83e-05	8.56e-05	CcSEcCtD
Rivastigmine—Vomiting—Dexamethasone—psoriasis	3.8e-05	8.49e-05	CcSEcCtD
Rivastigmine—Vomiting—Betamethasone—psoriasis	3.8e-05	8.49e-05	CcSEcCtD
Rivastigmine—Decreased appetite—Methotrexate—psoriasis	3.78e-05	8.45e-05	CcSEcCtD
Rivastigmine—Rash—Dexamethasone—psoriasis	3.77e-05	8.42e-05	CcSEcCtD
Rivastigmine—Rash—Betamethasone—psoriasis	3.77e-05	8.42e-05	CcSEcCtD
Rivastigmine—Dermatitis—Dexamethasone—psoriasis	3.76e-05	8.41e-05	CcSEcCtD
Rivastigmine—Dermatitis—Betamethasone—psoriasis	3.76e-05	8.41e-05	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Methotrexate—psoriasis	3.75e-05	8.39e-05	CcSEcCtD
Rivastigmine—Fatigue—Methotrexate—psoriasis	3.75e-05	8.38e-05	CcSEcCtD
Rivastigmine—Headache—Dexamethasone—psoriasis	3.74e-05	8.37e-05	CcSEcCtD
Rivastigmine—Headache—Betamethasone—psoriasis	3.74e-05	8.37e-05	CcSEcCtD
Rivastigmine—Asthenia—Prednisone—psoriasis	3.73e-05	8.35e-05	CcSEcCtD
Rivastigmine—Pain—Methotrexate—psoriasis	3.72e-05	8.31e-05	CcSEcCtD
Rivastigmine—Pruritus—Prednisone—psoriasis	3.68e-05	8.23e-05	CcSEcCtD
Rivastigmine—Feeling abnormal—Methotrexate—psoriasis	3.58e-05	8.01e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Prednisone—psoriasis	3.56e-05	7.96e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Methotrexate—psoriasis	3.56e-05	7.95e-05	CcSEcCtD
Rivastigmine—Nausea—Betamethasone—psoriasis	3.55e-05	7.93e-05	CcSEcCtD
Rivastigmine—Nausea—Dexamethasone—psoriasis	3.55e-05	7.93e-05	CcSEcCtD
Rivastigmine—Urticaria—Methotrexate—psoriasis	3.45e-05	7.72e-05	CcSEcCtD
Rivastigmine—Dizziness—Prednisone—psoriasis	3.44e-05	7.69e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Methotrexate—psoriasis	3.44e-05	7.68e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Methotrexate—psoriasis	3.44e-05	7.68e-05	CcSEcCtD
Rivastigmine—Vomiting—Prednisone—psoriasis	3.31e-05	7.4e-05	CcSEcCtD
Rivastigmine—Rash—Prednisone—psoriasis	3.28e-05	7.33e-05	CcSEcCtD
Rivastigmine—Dermatitis—Prednisone—psoriasis	3.28e-05	7.33e-05	CcSEcCtD
Rivastigmine—Headache—Prednisone—psoriasis	3.26e-05	7.29e-05	CcSEcCtD
Rivastigmine—Hypersensitivity—Methotrexate—psoriasis	3.2e-05	7.16e-05	CcSEcCtD
Rivastigmine—Asthenia—Methotrexate—psoriasis	3.12e-05	6.97e-05	CcSEcCtD
Rivastigmine—Nausea—Prednisone—psoriasis	3.09e-05	6.91e-05	CcSEcCtD
Rivastigmine—Pruritus—Methotrexate—psoriasis	3.08e-05	6.88e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Methotrexate—psoriasis	2.97e-05	6.65e-05	CcSEcCtD
Rivastigmine—Dizziness—Methotrexate—psoriasis	2.88e-05	6.43e-05	CcSEcCtD
Rivastigmine—Vomiting—Methotrexate—psoriasis	2.76e-05	6.18e-05	CcSEcCtD
Rivastigmine—Rash—Methotrexate—psoriasis	2.74e-05	6.13e-05	CcSEcCtD
Rivastigmine—Dermatitis—Methotrexate—psoriasis	2.74e-05	6.12e-05	CcSEcCtD
Rivastigmine—Headache—Methotrexate—psoriasis	2.72e-05	6.09e-05	CcSEcCtD
Rivastigmine—Nausea—Methotrexate—psoriasis	2.58e-05	5.77e-05	CcSEcCtD
